ID   ICAL_HUMAN              Reviewed;         708 AA.
AC   P20810; B7Z468; G5E946; G5E9D3; O95360; Q05DE8; Q7Z4K0; Q96D08; Q9H1Z5;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 4.
DT   07-APR-2021, entry version 194.
DE   RecName: Full=Calpastatin;
DE   AltName: Full=Calpain inhibitor;
DE   AltName: Full=Sperm BS-17 component;
GN   Name=CAST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS SER-408 AND GLY-592.
RX   PubMed=2577276; DOI=10.3109/14756368909030363;
RA   Asada K., Ishino Y., Shimada M., Shimojo T., Endo M., Kimizuka F., Kato I.,
RA   Maki M., Hatanaka M., Murachi T.;
RT   "cDNA cloning of human calpastatin: sequence homology among human, pig, and
RT   rabbit calpastatins.";
RL   J. Enzym. Inhib. 3:49-56(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=11978196;
RA   Zhu H., Zhou Z.-M., Li J.-M., Zhu H., Cheng L.-J., Shan Y.-X., Yin L.-L.,
RA   Sha J.H.;
RT   "Cloning and characterization of a novel isoform of calpastatin in human
RT   adult testis.";
RL   Acta Pharmacol. Sin. 23:450-454(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 10).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING
RP   (ISOFORMS 6 AND 7).
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-319 (ISOFORM 5).
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-479 (ISOFORM 8), AND VARIANT
RP   SER-408.
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-283 (ISOFORM 1), AND ALTERNATIVE SPLICING.
RC   TISSUE=Lung;
RX   PubMed=1569094;
RA   Lee W.J., Ma H., Takano E., Yang H.Q., Hatanaka M., Maki M.;
RT   "Molecular diversity in amino-terminal domains of human calpastatin by exon
RT   skipping.";
RL   J. Biol. Chem. 267:8437-8442(1992).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 101-317.
RX   PubMed=2553724;
RA   Maki M., Bagci H., Hamaguchi K., Ueda M., Murachi T., Hatanaka M.;
RT   "Inhibition of calpain by a synthetic oligopeptide corresponding to an exon
RT   of the human calpastatin gene.";
RL   J. Biol. Chem. 264:18866-18869(1989).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 125-283 (ISOFORMS 2/3).
RX   PubMed=2407243; DOI=10.1016/0006-291x(90)91035-q;
RA   Uemori T., Shimojo T., Asada K., Asano T., Kimizuka F., Kato I., Maki M.,
RA   Hatanaka M., Murachi T., Hanzawa H., Arata Y.;
RT   "Characterization of a functional domain of human calpastatin.";
RL   Biochem. Biophys. Res. Commun. 166:1485-1493(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 153-708 (ISOFORMS 2/3), SEQUENCE REVISION,
RP   AND VARIANT SER-408.
RA   Wang L.F.;
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 523-708 (ISOFORMS 1/2/3/4).
RC   TISSUE=Testis;
RX   PubMed=7951045;
RA   Wang L.F., Wei S.G., Miao S.Y., Liu Q.Y., Koide S.S.;
RT   "Calpastatin gene in human testis.";
RL   Biochem. Mol. Biol. Int. 33:245-252(1994).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-708 (ISOFORMS 1/2/3/4).
RC   TISSUE=Placenta;
RX   PubMed=7706496; DOI=10.1172/jci117870;
RA   Despres N., Talbot G., Plouffe B., Boire G., Menard H.A.;
RT   "Detection and expression of a cDNA clone that encodes a polypeptide
RT   containing two inhibitory domains of human calpastatin and its recognition
RT   by rheumatoid arthritis sera.";
RL   J. Clin. Invest. 95:1891-1896(1995).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 244-708 (ISOFORMS 1/2/3/4), AND VARIANT
RP   SER-408.
RC   TISSUE=Placenta;
RA   El-Amine M., Talbot G., Despres N., Asselin C., Boire G., Menard H.A.;
RL   Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 636-708 (ISOFORMS 1/2/3/4).
RA   Rochdi M.D., El-Amine M., Menard H.A.;
RT   "New calpastatin 3' UTR.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   PHOSPHORYLATION.
RX   PubMed=1995645;
RA   Adachi Y., Ishida-Takahashi A., Takahashi C., Takano E., Murachi T.,
RA   Hatanaka M.;
RT   "Phosphorylation and subcellular distribution of calpastatin in human
RT   hematopoietic system cells.";
RL   J. Biol. Chem. 266:3968-3972(1991).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-364; SER-366 AND
RP   SER-373, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; SER-575 AND SER-577,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 (ISOFORMS 10; 5; 6; 7 AND
RP   9), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; SER-373; SER-440;
RP   SER-563; SER-575 AND SER-577, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; SER-440; SER-516;
RP   SER-527; SER-575 AND SER-577, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [26]
RP   INVOLVEMENT IN PLACK.
RX   PubMed=25683118; DOI=10.1016/j.ajhg.2014.12.026;
RA   Lin Z., Zhao J., Nitoiu D., Scott C.A., Plagnol V., Smith F.J.,
RA   Wilson N.J., Cole C., Schwartz M.E., McLean W.H., Wang H., Feng C., Duo L.,
RA   Zhou E.Y., Ren Y., Dai L., Chen Y., Zhang J., Xu X., O'Toole E.A.,
RA   Kelsell D.P., Yang Y.;
RT   "Loss-of-function mutations in CAST cause peeling skin, leukonychia, acral
RT   punctate keratoses, cheilitis, and knuckle pads.";
RL   Am. J. Hum. Genet. 96:440-447(2015).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Specific inhibition of calpain (calcium-dependent cysteine
CC       protease). Plays a key role in postmortem tenderization of meat and
CC       have been proposed to be involved in muscle protein degradation in
CC       living tissue.
CC   -!- INTERACTION:
CC       P20810; P16333: NCK1; NbExp=2; IntAct=EBI-1268770, EBI-389883;
CC       P20810; Q9Z305; Xeno; NbExp=2; IntAct=EBI-1268770, EBI-9084208;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=P20810-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P20810-2; Sequence=VSP_000744;
CC       Name=3;
CC         IsoId=P20810-3; Sequence=VSP_000741, VSP_000744;
CC       Name=4;
CC         IsoId=P20810-4; Sequence=VSP_000742, VSP_000743;
CC       Name=5;
CC         IsoId=P20810-5; Sequence=VSP_038037, VSP_000744;
CC       Name=6;
CC         IsoId=P20810-6; Sequence=VSP_038038;
CC       Name=7;
CC         IsoId=P20810-7; Sequence=VSP_038038, VSP_000743;
CC       Name=8;
CC         IsoId=P20810-8; Sequence=VSP_000742;
CC       Name=9;
CC         IsoId=P20810-9; Sequence=VSP_047393;
CC       Name=10;
CC         IsoId=P20810-10; Sequence=VSP_038037;
CC   -!- DOMAIN: Each of the four flexible inhibitory domains can inhibit one
CC       calcium-bound calpain molecule by occupying both sides of the active
CC       site. {ECO:0000250}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- DISEASE: Peeling skin with leukonychia, acral punctate keratoses,
CC       cheilitis, and knuckle pads (PLACK) [MIM:616295]: An autosomal
CC       recessive disease characterized by generalized, continuous shedding of
CC       the outer layers of the epidermis, leukonychia, acral punctate
CC       keratosis, cheilitis, knuckle pads with multiple hyperkeratotic
CC       micropapules involving the interphalangeal joints, and palmoplantar
CC       keratoderma. {ECO:0000269|PubMed:25683118}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protease inhibitor I27 (calpastatin) family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH16066.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16217; BAA03747.1; -; mRNA.
DR   EMBL; D50827; BAA09438.1; -; mRNA.
DR   EMBL; AF327443; AAG48151.1; -; mRNA.
DR   EMBL; BT009783; AAP88785.1; -; mRNA.
DR   EMBL; AK296919; BAH12454.1; -; mRNA.
DR   EMBL; AC008906; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020900; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877037; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471084; EAW96068.1; -; Genomic_DNA.
DR   EMBL; CH471084; EAW96071.1; -; Genomic_DNA.
DR   EMBL; CH471084; EAW96075.1; -; Genomic_DNA.
DR   EMBL; BC013579; AAH13579.1; -; mRNA.
DR   EMBL; BC016066; AAH16066.1; ALT_SEQ; mRNA.
DR   EMBL; AL832349; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M86258; AAB59398.1; -; mRNA.
DR   EMBL; M28230; AAA52066.1; -; Genomic_DNA.
DR   EMBL; M28227; AAA52066.1; JOINED; Genomic_DNA.
DR   EMBL; M28228; AAA52066.1; JOINED; Genomic_DNA.
DR   EMBL; M28229; AAA52066.1; JOINED; Genomic_DNA.
DR   EMBL; M33328; AAA52296.1; -; mRNA.
DR   EMBL; U26724; AAC50136.2; -; mRNA.
DR   EMBL; S73329; AAB32311.1; -; mRNA.
DR   EMBL; U38525; AAA80684.1; -; mRNA.
DR   EMBL; U31345; AAB60371.1; -; mRNA.
DR   EMBL; U31346; AAB60372.1; -; mRNA.
DR   EMBL; AF095891; AAD09102.1; -; mRNA.
DR   CCDS; CCDS4082.1; -. [P20810-8]
DR   CCDS; CCDS43344.1; -. [P20810-10]
DR   CCDS; CCDS54882.1; -. [P20810-9]
DR   CCDS; CCDS54883.1; -. [P20810-2]
DR   PIR; A38091; A38091.
DR   RefSeq; NP_001035905.1; NM_001042440.4. [P20810-9]
DR   RefSeq; NP_001035906.1; NM_001042441.2. [P20810-7]
DR   RefSeq; NP_001035907.1; NM_001042442.2. [P20810-10]
DR   RefSeq; NP_001035908.1; NM_001042443.2. [P20810-1]
DR   RefSeq; NP_001035909.1; NM_001042444.2. [P20810-4]
DR   RefSeq; NP_001271141.1; NM_001284212.3.
DR   RefSeq; NP_001317560.1; NM_001330631.1. [P20810-2]
DR   RefSeq; NP_001741.4; NM_001750.6. [P20810-6]
DR   RefSeq; NP_775083.1; NM_173060.4. [P20810-8]
DR   RefSeq; XP_006714759.1; XM_006714696.3.
DR   RefSeq; XP_006714764.1; XM_006714701.3.
DR   RefSeq; XP_006714766.1; XM_006714703.3.
DR   RefSeq; XP_006714767.1; XM_006714704.3.
DR   RefSeq; XP_016865402.1; XM_017009913.1.
DR   SMR; P20810; -.
DR   BioGRID; 107281; 49.
DR   IntAct; P20810; 28.
DR   MINT; P20810; -.
DR   STRING; 9606.ENSP00000379157; -.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB01373; Calcium.
DR   MEROPS; I27.001; -.
DR   iPTMnet; P20810; -.
DR   MetOSite; P20810; -.
DR   PhosphoSitePlus; P20810; -.
DR   BioMuta; CAST; -.
DR   DMDM; 126302556; -.
DR   CPTAC; CPTAC-1023; -.
DR   CPTAC; CPTAC-1024; -.
DR   EPD; P20810; -.
DR   jPOST; P20810; -.
DR   MassIVE; P20810; -.
DR   MaxQB; P20810; -.
DR   PeptideAtlas; P20810; -.
DR   PRIDE; P20810; -.
DR   ProteomicsDB; 33826; -.
DR   ProteomicsDB; 33906; -.
DR   ProteomicsDB; 53796; -. [P20810-1]
DR   ProteomicsDB; 53797; -. [P20810-2]
DR   ProteomicsDB; 53798; -. [P20810-3]
DR   ProteomicsDB; 53799; -. [P20810-4]
DR   ProteomicsDB; 53800; -. [P20810-5]
DR   ProteomicsDB; 53801; -. [P20810-6]
DR   ProteomicsDB; 53802; -. [P20810-7]
DR   ProteomicsDB; 6573; -.
DR   TopDownProteomics; P20810-5; -. [P20810-5]
DR   Antibodypedia; 4008; 400 antibodies.
DR   DNASU; 831; -.
DR   Ensembl; ENST00000309190; ENSP00000312523; ENSG00000153113. [P20810-8]
DR   Ensembl; ENST00000338252; ENSP00000343421; ENSG00000153113. [P20810-2]
DR   Ensembl; ENST00000341926; ENSP00000339914; ENSG00000153113. [P20810-1]
DR   Ensembl; ENST00000395812; ENSP00000379157; ENSG00000153113. [P20810-9]
DR   Ensembl; ENST00000395813; ENSP00000379158; ENSG00000153113. [P20810-1]
DR   Ensembl; ENST00000508830; ENSP00000425721; ENSG00000153113. [P20810-6]
DR   Ensembl; ENST00000510756; ENSP00000422176; ENSG00000153113. [P20810-4]
DR   Ensembl; ENST00000674984; ENSP00000501713; ENSG00000153113. [P20810-10]
DR   Ensembl; ENST00000675033; ENSP00000501659; ENSG00000153113. [P20810-4]
DR   Ensembl; ENST00000675179; ENSP00000501872; ENSG00000153113. [P20810-6]
DR   GeneID; 831; -.
DR   KEGG; hsa:831; -.
DR   UCSC; uc003klt.4; human. [P20810-1]
DR   CTD; 831; -.
DR   DisGeNET; 831; -.
DR   GeneCards; CAST; -.
DR   HGNC; HGNC:1515; CAST.
DR   HPA; ENSG00000153113; Tissue enhanced (skeletal).
DR   MalaCards; CAST; -.
DR   MIM; 114090; gene.
DR   MIM; 616295; phenotype.
DR   neXtProt; NX_P20810; -.
DR   OpenTargets; ENSG00000153113; -.
DR   Orphanet; 444138; Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome.
DR   PharmGKB; PA26098; -.
DR   VEuPathDB; HostDB:ENSG00000153113.23; -.
DR   eggNOG; ENOG502RHIZ; Eukaryota.
DR   GeneTree; ENSGT00390000002993; -.
DR   InParanoid; P20810; -.
DR   OMA; IKEKDHT; -.
DR   OrthoDB; 203890at2759; -.
DR   PhylomeDB; P20810; -.
DR   TreeFam; TF332525; -.
DR   PathwayCommons; P20810; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   SIGNOR; P20810; -.
DR   BioGRID-ORCS; 831; 13 hits in 995 CRISPR screens.
DR   ChiTaRS; CAST; human.
DR   GeneWiki; Calpastatin; -.
DR   GenomeRNAi; 831; -.
DR   Pharos; P20810; Tbio.
DR   PRO; PR:P20810; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P20810; protein.
DR   Bgee; ENSG00000153113; Expressed in calcaneal tendon and 250 other tissues.
DR   ExpressionAtlas; P20810; baseline and differential.
DR   Genevisible; P20810; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:BHF-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0010859; F:calcium-dependent cysteine-type endopeptidase inhibitor activity; IMP:CAFA.
DR   GO; GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0097340; P:inhibition of cysteine-type endopeptidase activity; IMP:CAFA.
DR   GO; GO:2000675; P:negative regulation of type B pancreatic cell apoptotic process; IDA:BHF-UCL.
DR   GO; GO:1990709; P:presynaptic active zone organization; TAS:ARUK-UCL.
DR   DisProt; DP00196; -.
DR   InterPro; IPR026998; Calpastatin.
DR   InterPro; IPR001259; Prot_inh_calpain.
DR   PANTHER; PTHR10077; PTHR10077; 1.
DR   Pfam; PF00748; Calpain_inhib; 4.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Isopeptide bond;
KW   Palmoplantar keratoderma; Phosphoprotein; Protease inhibitor;
KW   Reference proteome; Repeat; Thiol protease inhibitor; Ubl conjugation.
FT   CHAIN           1..708
FT                   /note="Calpastatin"
FT                   /id="PRO_0000147632"
FT   REPEAT          170..222
FT                   /note="Inhibitory domain 1"
FT   REPEAT          304..356
FT                   /note="Inhibitory domain 2"
FT   REPEAT          446..499
FT                   /note="Inhibitory domain 3"
FT   REPEAT          583..636
FT                   /note="Inhibitory domain 4"
FT   MOD_RES         50
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P51125"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51125"
FT   MOD_RES         133
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         135
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P27321"
FT   MOD_RES         222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P51125"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         366
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         440
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         516
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         527
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         563
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         575
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         577
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   CROSSLNK        32
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..105
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11978196"
FT                   /id="VSP_000741"
FT   VAR_SEQ         1..62
FT                   /note="MNPTETKAIPVSQQMEGPHLPNKKKHKKQAVKTEPEKKSQSTKLSVVHEKKS
FT                   QEGKPKEHTE -> MSQPGQKPAASPRPRRAAAARRTHEHVSEKTSESPSKPGEKKGSD
FT                   EKKAASLGSSQSSRTYAGGTASATKVSASSGATSKSSSMNPTETKAVKTEPEKKSQSTK
FT                   (in isoform 9)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047393"
FT   VAR_SEQ         1..29
FT                   /note="MNPTETKAIPVSQQMEGPHLPNKKKHKKQ -> MSQPGQKPAASPRPRRAAA
FT                   ARRTHEHVSEKTSESPSKPGEKKGSDEKKAASLGSSQSSRTYAGGTASATKVSASSGAT
FT                   SKSSSMNPTETK (in isoform 5 and isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038037"
FT   VAR_SEQ         1
FT                   /note="M -> MSQPGQKPAASPRPRRAAAARRTHEHVSEKTSESPSKPGEKKGSDEK
FT                   KAASLGSSQSSRTYAGGTASATKVSASSGATSKSSSM (in isoform 6 and
FT                   isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_038038"
FT   VAR_SEQ         9..30
FT                   /note="Missing (in isoform 4 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005, ECO:0000303|Ref.3"
FT                   /id="VSP_000742"
FT   VAR_SEQ         44..62
FT                   /note="Missing (in isoform 4 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_000743"
FT   VAR_SEQ         212..224
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:11978196,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_000744"
FT   VARIANT         380
FT                   /note="E -> K (in dbSNP:rs1643702)"
FT                   /id="VAR_030741"
FT   VARIANT         408
FT                   /note="C -> S (in dbSNP:rs754615)"
FT                   /evidence="ECO:0000269|PubMed:17974005,
FT                   ECO:0000269|PubMed:2577276, ECO:0000269|Ref.12,
FT                   ECO:0000269|Ref.15"
FT                   /id="VAR_022686"
FT   VARIANT         537
FT                   /note="A -> V (in dbSNP:rs4948)"
FT                   /id="VAR_030742"
FT   VARIANT         592
FT                   /note="E -> G"
FT                   /evidence="ECO:0000269|PubMed:2577276"
FT                   /id="VAR_005298"
FT   CONFLICT        467
FT                   /note="R -> L (in Ref. 12; AAC50136)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        486..488
FT                   /note="VKD -> GKE (in Ref. 12; AAC50136)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        543
FT                   /note="V -> L (in Ref. 12; AAC50136)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        562
FT                   /note="Missing (in Ref. 15; AAB60371)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        651
FT                   /note="I -> V (in Ref. 16; AAD09102)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P20810-5:11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         P20810-6:11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         P20810-7:11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         P20810-9:11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         P20810-10:11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
SQ   SEQUENCE   708 AA;  76573 MW;  2DB0C14B860E89C7 CRC64;
     MNPTETKAIP VSQQMEGPHL PNKKKHKKQA VKTEPEKKSQ STKLSVVHEK KSQEGKPKEH
     TEPKSLPKQA SDTGSNDAHN KKAVSRSAEQ QPSEKSTEPK TKPQDMISAG GESVAGITAI
     SGKPGDKKKE KKSLTPAVPV ESKPDKPSGK SGMDAALDDL IDTLGGPEET EEENTTYTGP
     EVSDPMSSTY IEELGKREVT IPPKYRELLA KKEGITGPPA DSSKPIGPDD AIDALSSDFT
     CGSPTAAGKK TEKEESTEVL KAQSAGTVRS AAPPQEKKRK VEKDTMSDQA LEALSASLGT
     RQAEPELDLR SIKEVDEAKA KEEKLEKCGE DDETIPSEYR LKPATDKDGK PLLPEPEEKP
     KPRSESELID ELSEDFDRSE CKEKPSKPTE KTEESKAAAP APVSEAVCRT SMCSIQSAPP
     EPATLKGTVP DDAVEALADS LGKKEADPED GKPVMDKVKE KAKEEDREKL GEKEETIPPD
     YRLEEVKDKD GKPLLPKESK EQLPPMSEDF LLDALSEDFS GPQNASSLKF EDAKLAAAIS
     EVVSQTPAST TQAGAPPRDT SQSDKDLDDA LDKLSDSLGQ RQPDPDENKP MEDKVKEKAK
     AEHRDKLGER DDTIPPEYRH LLDDNGQDKP VKPPTKKSED SKKPADDQDP IDALSGDLDS
     CPSTTETSQN TAKDKCKKAA SSSKAPKNGG KAKDSAKTTE ETSKPKDD
//
